Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Optimizing Results of Unrelated Donor Hematopoietic Stem Cell Transplantion in Developing Countries: Young Age and Early Disease as Positive Factors for Survival.

Vaneuza A.M. Funke, MD, MS, Elenaide C. Nunes, MD, Eliane Cezario, MD PHD, Jefferson Ruiz, MD, Daniela C. Setubal, MD, Michel M. Oliveira, MD, Carmem M.S. Bonfim, MD, Marco A. Bitencourt, MD MS, Claudia Pettengil, MD, Larissa Medeiros, MD, Heliz Regina A. Neves Datamager, MS, Jose Zanis Neto, MD PHD, Carlos R. Medeiros, MD MS, Ricardo Pasquini, MD PHD

Blood (2006) 108 (11): 5404.

https://doi.org/10.1182/blood.V108.11.5404.5404

Published: 2006

Journal Articles

Long Term Results of Allogeneic Stem Cell Transplant for CML in Pediatric Patients: A Study of 50 Cases Transplanted over 20 Years in a Single Institution.

Vaneuza A.M. Funke, MD, MS, Claudia Pettengil, MD, Carmem M.S. Bonfim, MD, Jefferson Ruiz, MD, Marco A. Bitencourt, MD MS, Daniela C. Setubal, MD, Elenaide C. Nunes, MD, Michel M. Oliveira, MD, Ana Paula Azambuja, MD, Denise H. Lima, ARNP, Keiko T. Kojo, ARNP, Heliz Regina A. Neves Datamanager, MS, Jose Zanis Neto, MD, PHD, Carlos R. Medeiros, MD MS, Ricardo Pasquini, MD, PHD

Blood (2006) 108 (11): 5361.

https://doi.org/10.1182/blood.V108.11.5361.5361

Published: 2006

Journal Articles

Paroxysmal Nocturnal Hemoglobinuria (PNH): Long Term Follow up of 48 Patients in a Single Institution.

Jefferson Ruiz, MD, Larissa A. Medeiros, MD, Vaneuza A.M. Funke, MD MS, Carmem M.S. Bonfim, MD, Marco A. Bitencourt, MD MS, Daniela C. Setubal, MD, Claudia Pettengil, MD, Elenaide C. Nunes, MD, Michel M. Oliveira, MD, Jose Zanis Neto, MD PHD, Carlos R. Medeiros, MD MS, Mariester Malvezzi, MD MS, Ricardo Pasquini, MD PHD

Blood (2006) 108 (11): 3762.

https://doi.org/10.1182/blood.V108.11.3762.3762

Published: 2006

Journal Articles

Gleevec as Therapy for CML Relapsed after Allogeneic Stem Cell Transplantation: High Rate of BCR-ABL PCR Negativity and Donor Graft Reconstitution.

Vaneuza A.M. Funke, MD, MS, Samir K. Nabhan, MD, Michel M. Oliveira, MD, Jefferson Ruiz, MD, Daniela C. Setubal, MD, Ana Paula Azambuja, MD, Denise H. Lima, ARNP, Terezinha K. Kojo, ARNP, Henrique Bitencourt, MD, Nelson Hamerschlak, MD, Nelma Clementino, MD, Heliz Regina A. Neves, MS, Ricardo Pasquini, MD PHD

Blood (2006) 108 (11): 3671.

https://doi.org/10.1182/blood.V108.11.3671.3671

Published: 2006

Journal Articles

Five Years Update Results of Basiliximab (BAMAB) Therapy for Acute Refractory Graft Versus Host Disease (AGVHD).

Vaneuza A.M. Funke, MD, Carmem M. Bonfim, MD, Marco A. Bitencourt, MD, Daniela C. Setubal, MD, Jefferson Ruiz, MD, Carlos R. Medeiros, MD, Jose Z. Neto, PhD, Ricardo Pasquini, PhD

Blood (2004) 104 (11): 5083.

https://doi.org/10.1182/blood.V104.11.5083.5083

Published: 2004

NARROW

Optimizing Results of Unrelated Donor Hematopoietic Stem Cell Transplantion in Developing Countries: Young Age and Early Disease as Positive Factors for Survival.

Long Term Results of Allogeneic Stem Cell Transplant for CML in Pediatric Patients: A Study of 50 Cases Transplanted over 20 Years in a Single Institution.

Paroxysmal Nocturnal Hemoglobinuria (PNH): Long Term Follow up of 48 Patients in a Single Institution.

Gleevec as Therapy for CML Relapsed after Allogeneic Stem Cell Transplantation: High Rate of BCR-ABL PCR Negativity and Donor Graft Reconstitution.

Five Years Update Results of Basiliximab (BAMAB) Therapy for Acute Refractory Graft Versus Host Disease (AGVHD).

Email alerts

ASH Publications

American Society of Hematology

Optimizing Results of Unrelated Donor Hematopoietic Stem Cell Transplantion in Developing Countries: Young Age and Early Disease as Positive Factors for Survival.

Long Term Results of Allogeneic Stem Cell Transplant for CML in Pediatric Patients: A Study of 50 Cases Transplanted over 20 Years in a Single Institution.

Paroxysmal Nocturnal Hemoglobinuria (PNH): Long Term Follow up of 48 Patients in a Single Institution.

Gleevec as Therapy for CML Relapsed after Allogeneic Stem Cell Transplantation: High Rate of BCR-ABL PCR Negativity and Donor Graft Reconstitution.

Five Years Update Results of Basiliximab (BAMAB) Therapy for Acute Refractory Graft Versus Host Disease (AGVHD).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only